CALLICUTT JACK W sold GALT
November 5, 2025 · Form 4 insider transaction
CALLICUTT JACK W sold 200 shares of Galectin Therapeutics Inc. at $6.00 per share, a transaction worth $1.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$6.00
Total value
$1.2K
InsiderCALLICUTT JACK W
RoleOfficer
SecurityCommon stock
Transaction codeS: Open-market sale
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after7,614
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.